UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2024
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS. Employer Identification No.) | ||||||||||||
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
The | ||||||||||||||
The | ||||||||||||||
Item 2.02 Results of Operations and Financial Condition.
On August 8, 2024, Microvast Holdings, Inc. (the “Company”) issued a press release announcing its unaudited condensed consolidated financial results for the period ended June 30, 2024. In addition, the Company posted an accompanying slideshow presentation to its website summarizing its results for the same period. The full text of the press release is furnished as Exhibit 99.1 and the slideshow presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K. Exhibits 99.1 and 99.2 are hereby incorporated into this Item 2.02 by reference.
The information furnished in this Current Report on Form 8-K and Exhibits 99.1 and 99.2 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 8, 2024 | MICROVAST HOLDINGS, INC. | |||||||
| By: | /s/ Yaser Ali | |||||||
| Name: | Yaser Ali | |||||||
| Title: | Chief Financial Officer | |||||||
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits
Exhibit No. | Description | |||||||
| 99.1 | Press Release (Q2 2024) dated August 8, 2024 | |||||||
| 99.2 | Presentation (Q2 2024) dated August 8, 2024 | |||||||
2
Q 2 2 0 2 4
2 Disclaimer Forward-Looking Statements This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “believe,” “intend,” “plan,” “projection,” “guidance,” “outlook” or words of similar meaning. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements are based. All information set forth herein speaks only as of the date hereof and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication. Forecasts and estimates regarding Microvast’s industry and end markets are based on sources we believe to be reliable, however there can be no assurance these forecasts and estimates will prove accurate in whole or in part. Microvast’s annual, quarterly and other filings with the U.S. Securities and Exchange Commission identify, address and discuss these and other factors in the sections entitled “Risk Factors.” Non-GAAP Financial Measures This presentation contains adjusted gross profit, adjusted operating loss and adjusted net loss, which are non-GAAP financial measures. Adjusted gross profit is GAAP gross profit as adjusted for non-cash stock-based compensation expense included in cost of revenues. Adjusted operating loss is GAAP operating loss as adjusted for non-cash stock-based compensation expense included in cost of revenues and operating expense . Adjusted net loss is GAAP net loss as adjusted for non-cash stock-based compensation expense and change in on valuation of warrant and convertible loan. In addition to Microvast's results determined in accordance with GAAP, Microvast's management uses these non-GAAP financial metrics to evaluate the company’s ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial information, when taken collectively, may be helpful to investors in assessing Microvast's operating performance. We believe that the use of these non-GAAP metrics provides an additional tool for investors to use in evaluating ongoing operating results and trends because it eliminates the effect of financing, non-recurring items, capital expenditures, and non-cash expenses. In addition, our presentation of adjusted gross profit, adjusted operating loss and adjusted net loss should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our computation of non-GAAP financial metrics may not be comparable to other similarly titled measures computed by other companies because not all companies calculate these measures in the same fashion. Because of these limitations, these non-GAAP financial metrics should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. We compensate for these limitations by relying primarily on our GAAP results and using non-GAAP financial metrics on a supplemental basis. Investors should review the reconciliations in this presentation and not rely on any single financial measure to evaluate our business.
3Continued Focus – U.S. consolidation, Clarksville financing, operational efficiency, continue customer growth and expansion. Q2 2024 Overview Record Second Quarter 32.5% Q2 Gross Margin $84M Q2 Revenue Gross Profit $27M 137% increase Y/Y EMEA Revenue $47M 401% increase Y/Y Adj. Gross Margin +17% points Y/Y Revenues 12% increase Y/Y
Q 2 2 0 2 4 H I G H L I G H T S
5 HIGHLIGHTS 34.3% Adj. Gross Margin Robust Q2 Revenue Growth Expanding Commercial Vehicle Reach $84M Revenue 12% Y/Y Revenue Growth $279M Backlog Successes Debut in the European electric boat market through strategic partnership. Reinforcing partnership with MOL underlines Microvast’s leading position in the harbor and container handling equipment market. Entered strategic partnership with Evoy, a Norwegian pioneer in electric boat motor systems Secured follow-up orders from a leading European bus OEM Secured $40M order from Korean e-Bus customer Challenges Decelerated roll-out of light commercial vehicle platforms in European market. Delays in CV customer deliveries, pushed into 2H24. Q2 2024 Key Stats
6 Business Developments Growing New Markets OEM Vehicle Battery Type Highlights Prototype & first orders received, with delivery expected through 2026 Articulated e-Bus MpCO 48Ah Gen 4 MV-B & C pack HpCO-53.5Ah Gen 4 MV-B & C pack Orders received, expected up to $40M revenue in 2024 e-Bus HpCO-53.5Ah MV-I pack Strategic partnership in electric boat motor systems e-Boat Korean OEM Confidential EMEA Leading Bus OEM Confidential
Q 2 2 0 2 4 F I N A N C I A L S
8 Q2 2024 P&L ($ in thousands) GAAP Income Statement Three-Months Ended June 30 Six-Months Ended June 30 2023 2024 Y/Y (%) 2023 2024 Y/Y (%) Revenue 74,953 83,675 12% 121,926 165,026 35% Cost of revenues (63,492) (56,480) -11% (105,607) (120,606) 14% Gross Profit 11,461 27,195 137% 16,319 44,420 172% Gross Margin 15.3% 32.5% 113% 13.4% 26.9% 101% General and administrative expenses (23,509) (23,511) 0% (43,894) (47,305) 8% Research and development expenses (9,507) (10,107) 6% (20,368) (21,599) 6% Selling and marketing expenses (5,897) (5,026) -15% (10,885) (10,617) -2% Impairment loss of long-lived assets (51) (64,912) 127178% (51) (64,912) 127178% Operating expense (38,964) (103,556) 166% (75,198) (144,433) 92% Subsidy Income 637 735 15% 714 1,269 78% Operating loss (26,866) (75,626) 181% (58,165) (98,744) 70% Changes in fair value of warrant and convertible loan 0 (1,568) 100% 17 (1,526) -9076% Others 788 (1,247) -258% 2,499 (2,996) -220% Loss before income tax (26,078) (78,441) 201% (55,649) (103,266) 86% Income tax 0 0 0% 0 0 0% Net loss (26,078) (78,441) 201% (55,649) (103,266) 86% Less: net income attributable to noncontrolling interests 11 0 -100% 21 0 -100% Net loss attributable shareholders (26,089) (78,441) 201% (55,670) (103,266) 85%
9 Three-Months Ended June 30 Six-Months Ended June 30 Cost of Sales Adjustments 2023 2024 2023 2024 Three-Months Ended June 30 Six-Months Ended June 30 Revenue 74,953 83,675 121,926 165,026 2023 2024 2023 2024 Adjusted Cost of sales (non-GAAP) (61,967) (54,999) (102,578) (117,987) Non-Cash Settled SBC 1,525 1,481 3,029 2,619 Adjusted gross (loss) / profit (non-GAAP) 12,986 28,676 19,348 47,039 Adjusted gross margin (non-GAAP) 17.3% 34.3% 15.9% 28.5% Operating Expense Adjustments Adjusted Operating Expense (22,670) (92,907) (42,487) (123,055) Three-Months Ended June 30 Six-Months Ended June 30 Adjusted Operating Loss (non-GAAP) (9,047) (63,496) (22,425) (74,747) 2023 2024 2023 2024 Non-Cash Settled SBC 16,294 10,649 32,711 21,378 Adjusted Net Loss (non-GAAP) (8,259) (64,743) (19,926) (77,743) Net Loss Adjustments Three-Months Ended June 30 Six-Months Ended June 30 2023 2024 2023 2024 Fair Value Changes 0 1,568 (17) 1,526 Q2 2024 Adjusted Financials – Non-GAAP ($ in thousands)
10 Q2 2024 Revenue by Region ($ in thousands) Revenue by region Three-Months Ended June 30 2023 2024 Y/Y % APAC (Ex. China) 18,520 2,371 -87% China 46,122 33,282 -28% EMEA 9,337 46,745 401% USA 974 1,277 31% Total 74,953 83,675 12% Three-Months Ended June 30 Revenue by region Six-Months Ended June 30 2023 2024 Y/Y % APAC (Ex. China) 21,669 25,665 18% China 78,734 60,474 -23% EMEA 19,522 75,666 288% USA 2,001 3,221 61% Total 121,926 165,026 35% Six-Months Ended June 30 APAC (Ex. China), 3% China, 40% EMEA, 55% USA, 2% 2024 APAC (Ex. China), 16% China, 36% EMEA, 46% USA, 2% 2024
O U T L O O K
12 Global Continued focus on financing solutions to complete Clarksville and securing additional working capital. 2024 Core Focus – Maintain revenue growth and margin profile as catalysts to improved liquidity and route to breakeven. Q3 2024 Outlook $85-90M Q3 Revenue Guidance 6-12% Anticipated Q3 Revenue Growth Y/Y APAC 25% Targeted Gross Margin Targeting continued R&D progress and delivering prototype to new customers in Southeast Asian countries. Huzhou facility delivering new 21Ah cells to customers. EMEA Expected to ramp up series deliveries to European commercial vehicle OEMs. Q3 Revenue anticipated to grow >100% Y/Y Americas Exploring new commercial vehicle markets in the Americas. Targeting positive adjusted EBITDA contributions from APAC and EMEA in 2024. Profitability focus driving regional efficiency and growth.
13 New Battery Technology LFP-565Ah LFP Batteries: The Ideal Solution for Energy Storage Systems The newest product line in our extensive battery portfolio, the 565Ah LFP cell provides a host of specifications designed to meet the needs of renewable energy customers: • Lower Cost: LFP batteries are significantly less expensive than NMC batteries, resulting in savings for ESS customers. • Enhanced Reliability: LFP batteries are inherently more reliable with superior thermal stability, reducing the risk of fire or explosion. • Longer Lifespan: Specially designed LFP batteries provide a longer cycle life for ESS applications, ensuring reliable and durable performance over time. • Environmental Friendliness: LFP batteries do not contain cobalt, making them a more sustainable choice for scaled renewable energy operations. • Tax Credits: Our domestically produced LFP batteries are expected to qualify for IRA Section 45X, further enhancing their economic attractiveness for Microvast and our customers.
14 ME6 Energy Storage System Built to Last, Power When You Need It New Microvast ME6 Energy Storage Container Our new LFP-based ME6 energy storage solution offers a compelling combination of benefits, including: • Extra Long Life: Exceptional cycle life exceeding 10,000 cycles, up to 30-year lifespan with Microvast’s new overhaulable battery design. • Compact Storage: Boasts a high energy density offering of 6 MWh in a compact 21-foot container, allowing customers to optimize their construction and site layouts. • Top-Tier Reliability: IP55, C4, and nitrogen protection to prevent fires and resist corrosion for reliable year-round outdoor operation. • High Efficiency: Container includes an integrated modular cooling system, which extends the battery life and enhances round-trip efficiency. • Reduced TCO: Optimized total cost of ownership with a robust design and ability to continually maintain and overhaul product.
Exhibit 99.1
Microvast Reports Second Quarter 2024 Financial Results
•Record company Q2 revenue, increased 11.6% year over year to $83.7 million
•Gross margin increased from 15.3% to 32.5%, a 17.2 percentage point improvement year over year
STAFFORD, Texas, USA, August 8, 2024 — Microvast Holdings, Inc. (NASDAQ: MVST) (“Microvast” or the “Company”), a technology innovator that designs, develops and manufactures lithium-ion battery solutions, today announced unaudited condensed consolidated financial results for the second quarter ended June 30, 2024 (“Q2 2024”).
Results for Q2 2024
•Revenue of $83.7 million, compared to $75.0 million in Q2 2023, an increase of 11.6%
•Gross margin increased to 32.5% from gross margin of 15.3% in Q2 2023; Non-GAAP adjusted gross margin increased to 34.3%, up from 17.3% in Q2 2023
•Operating expenses of $103.6 million, compared to $39.0 million in Q2 2023; Adjusted operating expenses of $92.9 million, compared to $22.7 million in Q2 2023
•Net loss of $78.4 million, compared to net loss of $26.1 million in Q2 2023; Non-GAAP adjusted net loss of $64.7 million, compared to non-GAAP adjusted net loss of $8.3 million in Q2 2023
•Net loss per share of $0.25 compared to net loss per share of $0.08 in Q2 2023; Non-GAAP adjusted net loss per share of $0.21, compared to non-GAAP adjusted net loss per share of $0.02 in Q2 2023
•Adjusted EBITDA of negative $55.3 million in Q2 2024, compared to Adjusted EBITDA of negative $4.2 million in Q2 2023
•Capital expenditures of $2.9 million, compared to $57.7 million in Q2 2023
•Cash, cash equivalents, restricted cash and short-term investments of $104.5 million as of June 30, 2024, compared to $93.8 million as of December 31, 2023, and $195.8 million as of June 30, 2023
Please refer to the tables at the end of this press release for reconciliations of gross profit to non-GAAP adjusted gross profit, and net loss to non-GAAP adjusted net loss and non-GAAP adjusted EBITDA.
Q3 2024 Outlook
•For Q3 2024, the Company is targeting a revenue growth of 6% to 12% year over year and revenue guidance of $85 million to $90 million
•Targeting operational efficiencies, providing a Company gross margin target of 25%
•Ongoing R&D progress towards new product development, including launching the Company’s latest product, the 565Ah lithium iron phosphate (LFP) battery specifically tailored to our ESS solutions
•Shifting long-term U.S. ESS market focus to producing LFP battery systems instead of NMC battery solutions at its Clarksville, Tennessee facility and continuing to consolidate the Company’s U.S. operations in Clarksville
•Exploring strategic alternatives to enhance liquidity including the sale of certain U.S. non-core real estate assets
•Exploring new customer projects in the Americas, including Canada, and embarking on additional projects in APAC and EMEA that expand our presence in differentiated commercial vehicle markets
Webcast Information
Company management will host a conference call and webcast on August 8, 2024, at 4:00 p.m. Central Time, to discuss the Company's financial results. The live webcast and accompanying slide presentation will be accessible from the Events & Presentations section of Microvast’s investor relations website (https://ir.microvast.com/events-presentations/events). A replay will be available following the conclusion of the event.
About Microvast
Microvast is a global leader in providing battery technologies for electric vehicles and energy storage solutions. With a legacy of over 17 years, Microvast has consistently delivered cutting-edge battery systems that empower a cleaner and more sustainable future. The company's innovative approach and dedication to excellence have positioned it as a trusted partner for customers around the world. Microvast was founded in 2006 and is headquartered in Stafford, Texas.
For more information, please visit www.microvast.com.
Contact:
Investor Relations
ir@microvast.com
Cautionary Statement Regarding Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “plan,” “project,” “predict,” “outlook” “should,” “will,” “would,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. These forward-looking statements include, but are not limited to, statements regarding our industry and market sizes, and future opportunities for us. Such forward-looking statements are based upon the current beliefs and expectations of management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally
2
beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements.
Many factors could cause actual results and the timing of events to differ materially from the anticipated results or other expectations expressed in the forward-looking statements, including, among others: (1) our ability to remain a going concern; (2) risk that we may not be able to execute our growth strategies or achieve profitability; (3) risk that we will be unable to raise additional capital to execute our business plan or pay our debts as they come due, which may not be available on acceptable terms or at all; (4) restrictions in our existing and any future credit facilities; (5) risks of operations in China; (6) the effects of mechanics liens filed by contractors that we do not have sufficient funds to pay; (7) the effects of existing and future litigation; (8) changes in general economic conditions, including increases in interest rates and associated Federal Reserve policies, a potential economic recession, and the impact of inflation on our business; (9) changes in the highly competitive market in which we compete, including with respect to our competitive landscape, technology evolution or regulatory changes; (10) changes in availability and price of raw materials; (11) labor relations, including the ability to attract, hire and retain key employees and contract personnel; (12) heightened awareness of environmental issues and concern about global warming and climate change; (13) risk that we are unable to secure or protect our intellectual property; (14) risk that our customers or third-party suppliers are unable to meet their obligations fully or in a timely manner; (15) risk that our customers will adjust, cancel or suspend their orders for our products; (16) risk of product liability or regulatory lawsuits or proceedings relating to our products or services; (17) the effectiveness of our information technology and operational technology systems and practices to detect and defend against evolving cyberattacks; (18) changing laws regarding cybersecurity and data privacy, and any cybersecurity threat or event; (19) the effects and associated cost of compliance with existing and future laws and governmental regulations, such as the Inflation Reduction Act; (20) economic, financial and other impacts such as a pandemic, including global supply chain disruptions; and (21) the impacts of geopolitical events, including the ongoing conflicts between Russia and Ukraine and between Israel and Hamas. Microvast’s annual, quarterly and other filings with the U.S. Securities and Exchange Commission identify, address and discuss these and other factors in the sections entitled “Risk Factors.”
Actual results, performance or achievements may differ materially, and potentially adversely, from any forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as forward-looking statements are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control.
All information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date hereof except as may be required under applicable securities laws. Forecasts and estimates regarding our industry and end markets are based on sources we believe to be reliable, however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.
All references to the “Company,” “we,” “us” or “our” refer to Microvast Holdings, Inc. and its consolidated subsidiaries other than certain historical information which refers to the business of Microvast prior to the consummation of the Business Combination.
Non-GAAP Financial Measures
To provide investors with additional information regarding our financial results, Microvast has disclosed in this earnings release non-GAAP financial measures, including non-GAAP adjusted gross
3
profit (loss), non-GAAP adjusted EBITDA and non-GAAP adjusted net loss, which are non-GAAP financial measures as defined under the rules of the SEC. These are intended as supplemental measures of our financial performance that are not required by, or presented in accordance with U.S. generally accepted accounting principles (“GAAP”).
Reconciliations to the most comparable GAAP measures, gross profit and net income (loss), are contained in tabular form in the unaudited financial statements below. Non-GAAP adjusted gross profit is GAAP gross profit as adjusted for non-cash stock-based compensation expense included in cost of revenues. Non-GAAP adjusted net loss is GAAP net loss as adjusted for non-cash stock-based compensation expense and change in valuation of warrant and Convertible loan. Non-GAAP adjusted net loss per common share is GAAP net loss per common share as adjusted for non-cash stock-based compensation expense and change in valuation of warrant and Convertible loan per common share. Non-GAAP adjusted EBITDA is defined as net loss excluding depreciation and amortization, non-cash settled share-based compensation expense, interest expense, interest income, changes in fair value of our warrant and Convertible loan and income tax expense or benefit.
We use non-GAAP adjusted gross profit, non-GAAP adjusted EBITDA and non-GAAP adjusted net loss for financial and operational decision-making and as a means to evaluate period-to-period comparisons. We consider them to be important measures because they help illustrate underlying trends in our business and our historical operating performance on a more consistent basis. We believe that these non-GAAP financial measures, when taken together with their most directly comparable GAAP measures, gross profit and net income (loss), provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our recurring core business operating results.
We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors.
Non-GAAP financial measures have limitations as an analytical tool, and you should not consider them in isolation, or as a substitute for, financial information prepared in accordance with GAAP. For example, our calculation of non-GAAP adjusted EBITDA may differ from similarly titled non-GAAP measures, if any, reported by our peer companies, or our peer companies may use other measures to calculate their financial performance, and therefore our use of non-GAAP adjusted EBITDA may not be directly comparable to similarly titled measures of other companies. The principal limitation of non-GAAP adjusted EBITDA is that it excludes significant expenses and income that are required by GAAP to be recorded in our financial statements. In addition, it is subject to inherent limitations as it reflects the exercise of judgments by management about which expense and income are excluded or included in determining this non-GAAP financial measure. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. In addition, such financial information is unaudited and does not conform to SEC Regulation S-X and as a result, such information may be presented differently in our future filings with the SEC. For example, with respect to the warrant liability resulting from the merger, we now exclude changes in fair value from net loss in our non-GAAP adjusted EBITDA and non-GAAP adjusted net loss calculation, which had not been done in prior periods.
4
MICROVAST HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)
| December 31, 2023 | June 30, 2024 | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 44,541 | $ | 68,183 | |||||||
| Restricted cash, current | 37,477 | 34,737 | |||||||||
| Short-term investments | 5,634 | — | |||||||||
| Accounts receivable (net of allowance for credit losses of $4,571 and $4,679 as of December 31, 2023 and June 30, 2024, respectively) | 138,717 | 104,976 | |||||||||
| Notes receivable | 23,736 | 10,872 | |||||||||
| Inventories, net | 149,749 | 152,509 | |||||||||
| Prepaid expenses and other current assets | 25,752 | 16,675 | |||||||||
| Held-for-sale assets | — | 30,097 | |||||||||
| Total Current Assets | 425,606 | 418,049 | |||||||||
| Restricted cash, non-current | 6,171 | 1,564 | |||||||||
| Property, plant and equipment, net | 620,667 | 519,432 | |||||||||
| Land use rights, net | 11,984 | 11,565 | |||||||||
| Acquired intangible assets, net | 3,136 | 2,854 | |||||||||
| Operating lease right-of-use assets | 19,507 | 19,601 | |||||||||
| Other non-current assets | 9,661 | 11,494 | |||||||||
| Total Assets | $ | 1,096,732 | $ | 984,559 | |||||||
| Liabilities | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 112,618 | $ | 79,891 | |||||||
| Advance from customers | 43,087 | 40,810 | |||||||||
| Accrued expenses and other current liabilities | 148,284 | 142,773 | |||||||||
| Income tax payables | 655 | 653 | |||||||||
| Short-term bank borrowings | 35,392 | 60,034 | |||||||||
| Notes payable | 63,374 | 48,388 | |||||||||
| Total Current Liabilities | 403,410 | 372,549 | |||||||||
| Long-term bonds payable | 43,157 | 43,157 | |||||||||
| Long-term bank borrowings | 43,761 | 34,203 | |||||||||
| Warrant liability | 67 | 3 | |||||||||
| Share-based compensation liability | 199 | 190 | |||||||||
| Operating lease liabilities | 17,087 | 16,363 | |||||||||
| Convertible loan with shareholder | — | 13,313 | |||||||||
| Other non-current liabilities | 24,861 | 26,678 | |||||||||
| Total Liabilities | $ | 532,542 | $ | 506,456 | |||||||
| Shareholders’ Equity | |||||||||||
| Common Stock (par value of US$0.0001 per share, 750,000,000 and 750,000,000 shares authorized as of December 31, 2023 and June 30, 2024; 316,694,442 and 317,197,947 shares issued, and 315,006,942 and 315,510,447 shares outstanding as of December 31, 2023 and June 30, 2024) | $ | 32 | $ | 32 | |||||||
| Additional paid-in capital | 1,481,241 | 1,506,031 | |||||||||
| Statutory reserves | 6,032 | 6,032 | |||||||||
| Accumulated deficit | (897,501) | (1,000,767) | |||||||||
| Accumulated other comprehensive loss | (25,614) | (33,225) | |||||||||
| Total Equity | $ | 564,190 | $ | 478,103 | |||||||
| Total Liabilities and Equity | $ | 1,096,732 | $ | 984,559 | |||||||
5
MICROVAST HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2023 | 2024 | 2023 | 2024 | ||||||||||||||||||||
| Revenues | $ | 74,953 | $ | 83,675 | $ | 121,926 | $ | 165,026 | |||||||||||||||
| Cost of revenues | (63,492) | (56,480) | (105,607) | (120,606) | |||||||||||||||||||
| Gross profit | 11,461 | 27,195 | 16,319 | 44,420 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| General and administrative expenses | (23,509) | (23,511) | (43,894) | (47,305) | |||||||||||||||||||
| Research and development expenses | (9,507) | (10,107) | (20,368) | (21,599) | |||||||||||||||||||
| Selling and marketing expenses | (5,897) | (5,026) | (10,885) | (10,617) | |||||||||||||||||||
| Impairment loss of long-lived assets | (51) | (64,912) | (51) | (64,912) | |||||||||||||||||||
| Total operating expenses | (38,964) | (103,556) | (75,198) | (144,433) | |||||||||||||||||||
| Subsidy income | 637 | 735 | 714 | 1,269 | |||||||||||||||||||
| Loss from operations | (26,866) | (75,626) | (58,165) | (98,744) | |||||||||||||||||||
| Other income and expenses: | |||||||||||||||||||||||
| Interest income | 1,518 | 246 | 2,899 | 365 | |||||||||||||||||||
| Interest expense | (487) | (2,094) | (946) | (3,826) | |||||||||||||||||||
| Changes in fair value of warrant and convertible loan | — | (1,568) | 17 | (1,526) | |||||||||||||||||||
| Other (expense) income, net | (243) | 601 | 546 | 465 | |||||||||||||||||||
| Loss before provision for income taxes | (26,078) | (78,441) | (55,649) | (103,266) | |||||||||||||||||||
| Income tax expense | — | — | — | — | |||||||||||||||||||
| Net loss | $ | (26,078) | $ | (78,441) | $ | (55,649) | $ | (103,266) | |||||||||||||||
| Less: net income attributable to noncontrolling interests | 11 | — | 21 | — | |||||||||||||||||||
| Net loss attributable to Microvast Holdings, Inc.'s shareholders | $ | (26,089) | $ | (78,441) | $ | (55,670) | $ | (103,266) | |||||||||||||||
| Net loss per common share | |||||||||||||||||||||||
| Basic and diluted | $ | (0.08) | $ | (0.25) | $ | (0.18) | $ | (0.33) | |||||||||||||||
| Weighted average shares used in calculating net loss per share of common stock | |||||||||||||||||||||||
| Basic and diluted | 307,742,032 | 315,509,552 | 307,728,460 | 315,438,336 | |||||||||||||||||||
6
MICROVAST HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)
| Six Months Ended June 30, | |||||||||||
| 2023 | 2024 | ||||||||||
| Cash flows from operating activities | |||||||||||
| Net loss | $ | (55,649) | $ | (103,266) | |||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
| Loss/ (gain) on disposal of property, plant and equipment | 826 | 16 | |||||||||
| Interest expense | — | 622 | |||||||||
| Depreciation of property, plant and equipment | 9,797 | 14,912 | |||||||||
| Amortization of land use right and intangible assets | 399 | 387 | |||||||||
| Noncash lease expenses | 1,465 | 1,327 | |||||||||
| Share-based compensation | 35,779 | 23,988 | |||||||||
| Changes in fair value of warrant and convertible loan | (17) | 1,526 | |||||||||
| (Reversal)/ allowance of credit losses | (832) | 755 | |||||||||
| Write-down for obsolete inventories | 928 | 1,737 | |||||||||
| Impairment loss from long-lived asset | 51 | 64,912 | |||||||||
| Product warranty | 5,450 | 6,329 | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Notes receivable | (19,808) | 10,278 | |||||||||
| Accounts receivable | 10,251 | 29,622 | |||||||||
| Inventories | (16,610) | (1,454) | |||||||||
| Prepaid expenses and other current assets | (6,842) | 8,462 | |||||||||
| Operating lease right-of-use assets | (5,850) | (1,928) | |||||||||
| Other non-current assets | 199 | (44) | |||||||||
| Notes payable | (15,517) | (13,568) | |||||||||
| Accounts payable | 11,771 | (30,516) | |||||||||
| Advance from customers | (968) | (2,125) | |||||||||
| Accrued expenses and other liabilities | 1,020 | (12,374) | |||||||||
| Operating lease liabilities | 3,364 | (267) | |||||||||
| Other non-current liabilities | (215) | 2,811 | |||||||||
| Net cash (used in) generated from operating activities | (41,008) | 2,142 | |||||||||
| Cash flows from investing activities | |||||||||||
| Purchases of property, plant and equipment | (93,630) | (13,186) | |||||||||
| Proceeds on disposal of property, plant and equipment | 648 | 180 | |||||||||
| Purchase of short-term investments | (419) | — | |||||||||
| Proceeds from maturity of short-term investments | — | 5,564 | |||||||||
| Net cash used in investing activities | (93,401) | (7,442) | |||||||||
7
MICROVAST HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS-Continued
(In thousands of U.S. dollars, except share and per share data, or as otherwise noted)
| Six Months Ended June 30, | |||||||||||
| 2023 | 2024 | ||||||||||
| Cash flows from financing activities | |||||||||||
| Proceeds from borrowings | 9,232 | 40,462 | |||||||||
| Repayment of bank borrowings | (3,939) | (23,449) | |||||||||
| Convertible loan borrowing from a shareholder | — | 12,000 | |||||||||
| Payment for debt issue costs | — | (525) | |||||||||
| Net cash generated from financing activities | 5,293 | 28,488 | |||||||||
| Effect of exchange rate changes | (3,182) | (6,893) | |||||||||
| (Decrease) increase in cash, cash equivalents and restricted cash | (132,298) | 16,295 | |||||||||
| Cash, cash equivalents and restricted cash at beginning of the period | 302,617 | 88,189 | |||||||||
| Cash, cash equivalents and restricted cash at end of the period | $ | 170,319 | $ | 104,484 | |||||||
| Six Months Ended June 30, | |||||||||||
| 2023 | 2024 | ||||||||||
| Reconciliation to amounts on consolidated balance sheets | |||||||||||
| Cash and cash equivalents | $ | 142,766 | $ | 68,183 | |||||||
| Restricted cash | 27,553 | 36,301 | |||||||||
| Total cash, cash equivalents and restricted cash | $ | 170,319 | $ | 104,484 | |||||||
8
MICROVAST HOLDINGS, INC.
RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT
(Unaudited, in thousands of U.S. dollars)
RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT
(Unaudited, in thousands of U.S. dollars)
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2023 | 2024 | 2023 | 2024 | ||||||||||||||||||||
| Revenues | $ | 74,953 | $ | 83,675 | $ | 121,926 | $ | 165,026 | |||||||||||||||
| Cost of revenues | (63,492) | (56,480) | (105,607) | (120,606) | |||||||||||||||||||
| Gross profit (GAAP) | $ | 11,461 | $ | 27,195 | $ | 16,319 | $ | 44,420 | |||||||||||||||
| Gross margin | 15.3 | % | 32.5 | % | 13.4 | % | 26.9 | % | |||||||||||||||
| Non-cash settled share-based compensation (included in cost of revenues) | 1,525 | 1,481 | 3,029 | 2,619 | |||||||||||||||||||
| Adjusted gross profit (non-GAAP) | $ | 12,986 | $ | 28,676 | $ | 19,348 | $ | 47,039 | |||||||||||||||
| Adjusted gross margin (non-GAAP) | 17.3 | % | 34.3 | % | 15.9 | % | 28.5 | % | |||||||||||||||
9
MICROVAST HOLDINGS, INC.
RECONCILIATION OF NET LOSS TO ADJUSTED NET LOSS
(In thousands of U.S. dollars, except per share data, or as otherwise noted)
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2023 | 2024 | 2023 | 2024 | ||||||||||||||||||||
| Net loss (GAAP) | $ | (26,078) | $ | (78,441) | $ | (55,649) | $ | (103,266) | |||||||||||||||
Changes in fair value of warrant and Convertible loan* | — | 1,568 | (17) | 1,526 | |||||||||||||||||||
| Non-cash settled share-based compensation* | 17,819 | 12,130 | 35,740 | 23,997 | |||||||||||||||||||
| Adjusted Net Loss (non-GAAP) | $ | (8,259) | $ | (64,743) | $ | (19,926) | $ | (77,743) | |||||||||||||||
*The tax effect of the adjustments was nil.
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2023 | 2024 | 2023 | 2024 | ||||||||||||||||||||
| Net loss per common share-Basic and diluted (GAAP) | $ | (0.08) | $ | (0.25) | $ | (0.18) | $ | (0.33) | |||||||||||||||
| Changes in fair value of warrant and Convertible loan per common share | — | — | — | — | |||||||||||||||||||
| Non-cash settled share-based compensation per common share | 0.06 | 0.04 | 0.12 | 0.08 | |||||||||||||||||||
| Adjusted net loss per common share-Basic and diluted (non-GAAP) | $ | (0.02) | $ | (0.21) | $ | (0.06) | $ | (0.25) | |||||||||||||||
10
MICROVAST HOLDINGS, INC.
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA
(Unaudited, in thousands of U.S. dollars)
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA
(Unaudited, in thousands of U.S. dollars)
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2023 | 2024 | 2023 | 2024 | ||||||||||||||||||||
| Net loss (GAAP) | $ | (26,078) | $ | (78,441) | $ | (55,649) | $ | (103,266) | |||||||||||||||
| Interest (income) expense, net | (1,031) | 1,848 | (1,953) | 3,461 | |||||||||||||||||||
| Income tax expense | — | — | — | — | |||||||||||||||||||
| Depreciation and amortization | 5,099 | 7,635 | 10,196 | 15,299 | |||||||||||||||||||
| EBITDA (non-GAAP) | $ | (22,010) | $ | (68,958) | $ | (47,406) | $ | (84,506) | |||||||||||||||
| Changes in fair value of warrant and convertible loan | — | 1,568 | (17) | 1,526 | |||||||||||||||||||
| Non-cash settled share-based compensation | 17,819 | 12,130 | 35,740 | 23,997 | |||||||||||||||||||
| Adjusted EBITDA (non-GAAP) | $ | (4,191) | $ | (55,260) | $ | (11,683) | $ | (58,983) | |||||||||||||||
11